This inventor holds 26 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Neurogen Corporation, Pfizer Corporation. Active years: 1997-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New Haven, CT (US) (1997 - 2002)
- Madison, CT (US) (2002 - 2006)
- Durham, CT (US) (2004 - 2010)
Company Filing History:
Years Active: 1997-2010
Areas of Expertise:
Title: **Innovative Contributions of John M Peterson in Pharmaceutical Patents**
Introduction
John M Peterson, an accomplished inventor based in Durham, CT, has made significant contributions to the field of pharmaceuticals, evidenced by his impressive portfolio of 26 patents. His innovations primarily focus on compounds that modulate ligand binding to histamine H3 receptors, which are crucial in the treatment of various disorders in both humans and animals.
Latest Patents
Among his latest patents, Peterson has developed several noteworthy compounds:
1. **Dipiperazinyl Ketones and Related Analogues** - These compounds offer methods for preparation and use, with applications in modulating ligand binding to histamine H3 receptors. They have potential therapeutic uses in treating various disorders in humans, domesticated companion animals, and livestock. Additionally, the patent provides pharmaceutical compositions and methods for detecting histamine H3 receptors.
2. **Thiazole Amides, Imidazole Amides and Related Analogues** - This patent presents compounds that modulate ligand binding to histamine H3 receptors, targeting both central nervous system (CNS) and other disorders. These compounds can be administered alone or in combination with other CNS agents to enhance their effects, along with pharmaceutical compositions and detection methods for histamine H3 receptors.
Career Highlights
Throughout his career, John M Peterson has worked with notable companies in the pharmaceutical industry, including Neurogen Corporation and Pfizer Corporation. His tenure at these organizations has greatly influenced his work, allowing him to innovate within the field.
Collaborations
Collaboration has been key to Peterson's success. He has partnered with esteemed colleagues such as Alan J Hutchison and Andrew Y Thurkauf, exchanging ideas that have propelled his inventive works further into the realm of pharmaceutical advancements.
Conclusion
John M Peterson's extensive patent portfolio and collaborative efforts reflect his commitment to advancing medical treatments through innovative pharmaceutical compounds. His work continues to have a significant impact on the modulation of histamine H3 receptors, paving the way for new therapeutic approaches in managing various health disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile